Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation
Extracellular vehicles (EVs) are efficient biomarkers of disease and participate in disease pathogenesis; however, their use as clinical therapies to modify disease outcomes remains to be determined. Cell-based immune therapies, including regulatory T cells (Tregs), are currently being clinically ev...
Main Authors: | Aaron D. Thome, Jason R. Thonhoff, Weihua Zhao, Alireza Faridar, Jinghong Wang, David R. Beers, Stanley H. Appel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.875825/full |
Similar Items
-
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease
by: Alireza Faridar, et al.
Published: (2022-09-01) -
The Role and Impact of Extracellular Vesicles in the Modulation and Delivery of Cytokines during Autoimmunity
by: Mohammed Tayab Hussain, et al.
Published: (2020-09-01) -
Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
by: Aaron D. Thome, et al.
Published: (2021-05-01) -
Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks
by: Sarah Beck, et al.
Published: (2022-03-01) -
Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury
by: Vivian A. Guedes, et al.
Published: (2020-07-01)